Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation
about
Cannabinoids for the treatment of dementiaCannabinoids for the treatment of dementiaThe search for novel analgesics: targets and mechanismsInterferon-gamma is a critical modulator of CB(2) cannabinoid receptor signaling during neuropathic painCrucial role of CB(2) cannabinoid receptor in the regulation of central immune responses during neuropathic painCB2 receptor-mediated migration of immune cells: it can go either wayEmerging role of the cannabinoid receptor CB2 in immune regulation: therapeutic prospects for neuroinflammationThe CB2 cannabinoid agonist AM-1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onsetThe cannabinoid CB2 receptor as a target for inflammation-dependent neurodegenerationAlzheimer's disease; taking the edge off with cannabinoids?CB2 Cannabinoid Receptor As Potential Target against Alzheimer's DiseaseMicroglial Cells as a Link between Cannabinoids and the Immune Hypothesis of Psychiatric DisordersR-flurbiprofen reduces neuropathic pain in rodents by restoring endogenous cannabinoidsCannabinoids and Epilepsy.Precision Medicine in Multiple Sclerosis: Future of PET Imaging of Inflammation and Reactive AstrocytesPharmacotherapeutic modulation of the endocannabinoid signalling system in psychiatric disorders: drug-discovery strategiesBrain neuronal CB2 cannabinoid receptors in drug abuse and depression: from mice to human subjectsFunctional expression of brain neuronal CB2 cannabinoid receptors are involved in the effects of drugs of abuse and in depressionEndocannabinoid system and psychiatry: in search of a neurobiological basis for detrimental and potential therapeutic effects.Prolonged oral cannabinoid administration prevents neuroinflammation, lowers β-amyloid levels and improves cognitive performance in Tg APP 2576 mice.Mutant huntingtin impairs immune cell migration in Huntington disease.Analgesic effect of a mixed T-type channel inhibitor/CB2 receptor agonist.(-)-β-Caryophyllene, a CB2 Receptor-Selective Phytocannabinoid, Suppresses Motor Paralysis and Neuroinflammation in a Murine Model of Multiple Sclerosis.Brain CB₂ Receptors: Implications for Neuropsychiatric Disorders.Palmitoylethanolamide induces microglia changes associated with increased migration and phagocytic activity: involvement of the CB2 receptorCannabinoids as novel anti-inflammatory drugs.Targeting the endocannabinoid system in Alzheimer's disease.The endocannabinoid system as a target for the treatment of neurodegenerative disease.CB2 Cannabinoid receptors as a therapeutic target-what does the future hold?Endocannabinoids prevent β-amyloid-mediated lysosomal destabilization in cultured neurons.Cannabinoid Receptor 2 Signaling in Neurodegenerative Disorders: From Pathogenesis to a Promising Therapeutic Target.HIV-1 infection and alcohol abuse: neurocognitive impairment, mechanisms of neurodegeneration and therapeutic interventions.Immunoregulation of a CB2 receptor agonist in a murine model of neuroAIDSAn amyloid β42-dependent deficit in anandamide mobilization is associated with cognitive dysfunction in Alzheimer's disease.High-intensity cannabis use associated with lower plasma human immunodeficiency virus-1 RNA viral load among recently infected people who use injection drugsEndocannabinoids and traumatic brain injuryCannabinoid neuroimmune modulation of SIV disease.Alkylindole-sensitive receptors modulate microglial cell migration and proliferation.WIN 55,212-2, agonist of cannabinoid receptors, prevents amyloid β1-42 effects on astrocytes in primary culture.Cannabinoid CB2 Receptors in a Mouse Model of Aβ Amyloidosis: Immunohistochemical Analysis and Suitability as a PET Biomarker of Neuroinflammation
P2860
Q24241582-111254CD-86A1-4E07-9ACC-11C1BC3CC6A2Q24242873-F2B8F8FF-A354-4E83-BA37-94ADEBACE311Q24288817-B85533D2-C5BD-4673-A18B-B4BAF68EA516Q24634125-57D57FAA-57D7-4C90-A4F0-94D829806C75Q24634161-A319AC12-E60C-4C87-AB3F-A6EB4D939A40Q24643591-43E5F70E-43D9-476D-A90F-7DBB64224B8DQ24647850-248D2256-3790-4F76-B627-497E529A1F70Q24650098-193AB7F7-051D-4274-958A-3306B8F25761Q24651712-06B132FA-1E4E-4C81-B15D-4983ED394BF3Q24681412-9C8A6307-AD8A-455B-A17C-807609196BB2Q26746050-159C45E5-0724-4778-AE5E-1517CBFFC057Q26767489-7C28AA21-A2FE-4880-A5E1-CA7BF8AC79A6Q27329150-8D308B0C-BE49-4287-A6EB-EBEFA4350E87Q27336451-D1412DB8-A3D0-42D9-A1BB-1E5A78A85DCFQ28078621-A15A220E-E492-4E42-BE36-DF0F34ED677EQ28241318-DD09B391-200A-4861-8C0A-C2F20465CE0FQ28472191-DFE8C4D0-2C5D-48F9-9946-8798980C670CQ28566269-95196D17-E7FC-4935-8D6F-AA9F831E76DBQ30473707-4D1EB0A5-6949-463E-9682-F818B9BA1C82Q30506148-068AD4FD-3385-45A7-BB06-AB2EA4428410Q30530945-5997BF4F-875F-436D-A0BA-F4723CEF2513Q30541205-6B97F2CD-76B8-4798-93BB-4E6BF225610BQ33624245-F061C28F-BD67-4CC3-888E-AD0EB5029C25Q33664105-FC35D504-0BD1-4506-B36B-8DE122E34B39Q33671206-97BC1EB1-DD84-449F-9444-AEBF98C492D1Q33688381-551666DB-162E-45DE-8E4C-F7CFB4B2AEC5Q33930000-62C22AA5-5C7E-489F-ACF9-0540404AFDC3Q34098196-9470570E-5C24-4CA0-9433-29A41186B44DQ34186015-AABA5BF9-EEAE-4B8F-8971-C0FFBE224EAEQ34352311-D7B9B23D-E386-41D0-B44A-545715048A1AQ34680801-58EA1C7E-E934-43B6-80FC-6130AA792EABQ34993393-D0FEC526-7201-43B0-B670-14681A13FF1EQ35028750-06305B76-EC03-4C22-8606-45DA16219D79Q35159081-051007C2-B680-462A-B480-7CFA33446171Q35186458-508D4FA8-BAAC-4FF5-A24E-ED71D35D86C3Q35193282-F47BEDCE-50FB-4C36-AEE9-50D7CABC8279Q35529056-CC69DA8A-4F93-4FA0-8455-B32B9A08A14EQ35564928-BDF58F55-6B12-4680-AEC7-9EB55986509CQ35601542-5140CAFD-02F1-40E7-A0F5-0FCE3F85C24AQ35667387-A8A5D5D2-40A8-4673-BA06-CCCD0EDA85C4
P2860
Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation
description
2005 nî lūn-bûn
@nan
2005 թուականին հրատարակուած գիտական յօդուած
@hyw
2005 թվականին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation
@ast
Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation
@en
Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation
@en-gb
Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation
@nl
type
label
Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation
@ast
Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation
@en
Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation
@en-gb
Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation
@nl
prefLabel
Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation
@ast
Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation
@en
Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation
@en-gb
Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation
@nl
P2093
P2860
P921
P3181
P356
P1476
Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation
@en
P2093
Demian Obregon
Francisco Fernandez
Huayan Hou
Jared Ehrhart
R Douglas Shytle
Takashi Mori
Thomas Klein
P2860
P2888
P3181
P356
10.1186/1742-2094-2-29
P407
P577
2005-01-01T00:00:00Z
P5875
P6179
1018958413